Filing Details

Accession Number:
0000950170-24-042289
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-04-05 16:30:08
Reporting Period:
2024-04-03
Accepted Time:
2024-04-05 16:30:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1556263 Syros Pharmaceuticals Inc. SYRS Pharmaceutical Preparations (2834) 453772460
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1599014 David Roth C/O Syros Pharmaceuticals, Inc.
35 Cambridgepark Drive
Cambridge MA 02140
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-04-03 10,451 $4.95 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported on this Form 4 was effected pursuant to a trading plan adopted on March 27, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.